Clamping down on Corporate Bribery  

作　　者：Yin Pumin 

出　　处：《Beijing Review》2013年第31期36-37,共2页北京周报（英文版）

摘　　要：Allegations of corruption by a multinational drug company once again draw attention toanever-ending fight British drug maker GlaxoSmithKline（GSK）has been mired in allegations of corruption in China recently.On July 11,the Ministry of Public Security（MPS）declared that it has investigated more than 20 employees and detained four senior Chinese executives from GSK China on allegations of offeringAllegations of corruption by a multinational drug company once again draw attention toanever-ending fight British drug maker GlaxoSmithKline(GSK)has been mired in allegations of corruption in China recently.On July 11,the Ministry of Public Security(MPS)declared that it has investigated more than 20 employees and detained four senior Chinese executives from GSK China on allegations of

关 键 词：企业 高级管理人员 制药公司 公众安全 中国 MPS 腐败 

分 类 号：D922.294[政治法律—经济法学]